Literature DB >> 17888739

Creation and characterisation of a high-copy-number version of the pAL5000 mycobacterial replicon.

William R Bourn1, Yvette Jansen, Helen Stutz, Robin M Warren, Anna-Lise Williamson, Paul D van Helden.   

Abstract

The majority of mycobacterial plasmid vectors are derived from the pAL5000 replicon and maintained at approximately five copies per cell. We have devised a method that directly selects for high-copy-number plasmids. This involves enriching for high copy number plasmids by repeatedly isolating and retransforming plasmids from a mutant library. Using this method we have selected a copy-up version of the pAL5000 replicon. In Mycobacterium smegmatis the copy-number was shown to have increased 7-fold to between 32 and 64 copies/cell, and the plasmid remained relatively stable after 100 generations in the absence of antibiotic selection. The plasmid also has a high-copy-number phenotype in M. bovis BCG and can be used to increase expression of cloned genes, as we have demonstrated with the green fluorescent protein. The mutation was found to be the deletion of an alanine residue in the C-terminal end of the RepA replication protein. We argue that the mutation exerts its effect through altered RNA folding, thereby affecting the translationally coupled RepA-RepB expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17888739     DOI: 10.1016/j.tube.2007.08.003

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  12 in total

1.  Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria.

Authors:  Christopher H Miller; Shahista Nisa; Sandi Dempsey; Cameron Jack; Ronan O'Toole
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

Review 2.  Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.

Authors:  Rosamund Chapman; Gerald Chege; Enid Shephard; Helen Stutz; Anna-Lise Williamson
Journal:  Curr HIV Res       Date:  2010-06       Impact factor: 1.581

3.  Targeting the chromosome partitioning protein ParA in tuberculosis drug discovery.

Authors:  Shahista Nisa; Marian C J Blokpoel; Brian D Robertson; Joel D A Tyndall; Shichun Lun; William R Bishai; Ronan O'Toole
Journal:  J Antimicrob Chemother       Date:  2010-09-01       Impact factor: 5.790

4.  Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.

Authors:  Tianyu Zhang; William R Bishai; Jacques H Grosset; Eric L Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

5.  RNase HI Depletion Strongly Potentiates Cell Killing by Rifampicin in Mycobacteria.

Authors:  Abeer Al-Zubaidi; Chen-Yi Cheung; Gregory M Cook; George Taiaroa; Valerie Mizrahi; J Shaun Lott; Stephanie S Dawes
Journal:  Antimicrob Agents Chemother       Date:  2022-09-26       Impact factor: 5.938

6.  Optimisation of bioluminescent reporters for use with mycobacteria.

Authors:  Nuria Andreu; Andrea Zelmer; Taryn Fletcher; Paul T Elkington; Theresa H Ward; Jorge Ripoll; Tanya Parish; Gregory J Bancroft; Ulrich Schaible; Brian D Robertson; Siouxsie Wiles
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

7.  Sensitive detection of gene expression in mycobacteria under replicating and non-replicating conditions using optimized far-red reporters.

Authors:  Paul Carroll; Lise J Schreuder; Julian Muwanguzi-Karugaba; Siouxsie Wiles; Brian D Robertson; Jorge Ripoll; Theresa H Ward; Gregory J Bancroft; Ulrich E Schaible; Tanya Parish
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

8.  Genetic alteration of Mycobacterium smegmatis to improve mycobacterium-mediated transfer of plasmid DNA into mammalian cells and DNA immunization.

Authors:  Yongkai Mo; Natalie M Quanquin; William H Vecino; Uma Devi Ranganathan; Lydia Tesfa; William Bourn; Keith M Derbyshire; Norman L Letvin; William R Jacobs; Glenn J Fennelly
Journal:  Infect Immun       Date:  2007-07-30       Impact factor: 3.441

9.  The development of a novel Mycobacterium-Escherichia coli shuttle vector system using pMyong2, a linear plasmid from Mycobacterium yongonense DSM 45126T.

Authors:  Hyungki Lee; Byoung-Jun Kim; Bo-Ram Kim; Yoon-Hoh Kook; Bum-Joon Kim
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

10.  Endonuclease IV Is the major apurinic/apyrimidinic endonuclease in Mycobacterium tuberculosis and is important for protection against oxidative damage.

Authors:  Rupangi Verma Puri; Nisha Singh; Rakesh K Gupta; Anil K Tyagi
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.